Dual Fulvestrant-Trametinib Therapy in Recurrent Low-Grade Serous Ovarian Cancer.
Dual Fulvestrant-Trametinib Therapy in Recurrent Low-Grade Serous Ovarian Cancer.
Oncologist. 2020 May 05;:
Authors: Bussies P, Schlumbrecht M
PMID: 32369640 [PubMed - as supplied by publisher]
Source: The Oncologist - Category: Cancer & Oncology Authors: Bussies P, Schlumbrecht M Tags: Oncologist Source Type: research